Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

907 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors for Side Branch Failure During Provisional Strategy of Coronary Intervention for Bifurcation Lesions (from the Korean Bifurcation Registry).
Seo JB, Shin DH, Park KW, Koo BK, Gwon HC, Jeong MH, Seong IW, Rha SW, Yang JY, Park SJ, Yoon JH, Han KR, Park JS, Hur SH, Tahk SJ, Kim HS. Seo JB, et al. Among authors: koo bk. Am J Cardiol. 2016 Sep 15;118(6):797-803. doi: 10.1016/j.amjcard.2016.06.049. Epub 2016 Jun 28. Am J Cardiol. 2016. PMID: 27523437
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK, Kim SY, Chang HJ, Lee W, Kang WJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH, Park YB, Kim HS. Kang HJ, et al. Among authors: koo bk. Circulation. 2006 Jul 4;114(1 Suppl):I145-51. doi: 10.1161/CIRCULATIONAHA.105.001107. Circulation. 2006. PMID: 16820564 Clinical Trial.
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Jo SH, et al. Among authors: koo bk. J Am Coll Cardiol. 2006 Sep 5;48(5):924-30. doi: 10.1016/j.jacc.2006.06.047. Epub 2006 Aug 17. J Am Coll Cardiol. 2006. PMID: 16949481 Free article. Clinical Trial.
Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
Lee HY, Chung JW, Youn SW, Kim JY, Park KW, Koo BK, Oh BH, Park YB, Chaqour B, Walsh K, Kim HS. Lee HY, et al. Among authors: koo bk. Circ Res. 2007 Feb 16;100(3):372-80. doi: 10.1161/01.RES.0000257945.97958.77. Epub 2007 Jan 18. Circ Res. 2007. PMID: 17234971
Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial.
Kang HJ, Kim HS, Koo BK, Kim YJ, Lee D, Sohn DW, Oh BH, Park YB. Kang HJ, et al. Among authors: koo bk. Am Heart J. 2007 Feb;153(2):237.e1-8. doi: 10.1016/j.ahj.2006.11.004. Am Heart J. 2007. PMID: 17239682 Clinical Trial.
Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial.
Tahk SJ, Choi BJ, Choi SY, Yoon MH, Gwon HC, Hong GR, Kim YJ, Hur SH, Kim KB, Koo BK, Lee SH, Yoon J. Tahk SJ, et al. Among authors: koo bk. Int J Cardiol. 2008 Jan 11;123(2):162-8. doi: 10.1016/j.ijcard.2007.03.124. Epub 2007 May 8. Int J Cardiol. 2008. PMID: 17490759 Clinical Trial.
907 results